__NUXT_JSONP__("/drugs/Lutetium_Lu_177_PP-F11N", (function(a,b,c,d){return {data:[{drug:{slug:b,emaEpar:[],fdaDrugLabel:[],id:b,nciThesaurus:{casRegistry:a,chebiId:a,chemicalFormula:a,definition:"A radioconjugate composed of PP-F11N, a gastrin analog, conjugated to the beta-emitting radioisotope lutetium Lu 177, with potential antineoplastic activity and potential use as an imaging agent for scintigraphy. Following intravenous administration, the PP-F11N moiety binds to the cholecystokinin-2 (CCK-2) receptor. Subsequently, the CCK-2 receptor-expressing tumor cells can be visualized scintigraphically. In addition, the radioisotope moiety delivers a cytotoxic dose of beta radiation to CCK-2 receptor-expressing tumor cells. CCK-2 receptors are expressed on a variety of tumor cell types.",fdaUniiCode:"639NVQ0SXF",identifier:"C114499",preferredName:c,semanticType:"Pharmacologic Substance",subclassOf:["C129819","C2124"],synonyms:["177Lu-PP-F11N",c,"PP-F11N LUTETIUM LU-177"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FLutetium_Lu_177_PP-F11N",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("","Lutetium_Lu_177_PP-F11N","Lutetium Lu 177 PP-F11N","2021-10-30T13:18:48.083Z")));